191 related articles for article (PubMed ID: 29385536)
1. Pumilio directs deadenylation-associated translational repression of the cyclin-dependent kinase 1 activator RGC-32.
Brocard M; Khasnis S; Wood CD; Shannon-Lowe C; West MJ
Nucleic Acids Res; 2018 Apr; 46(7):3707-3725. PubMed ID: 29385536
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of the cell-cycle regulator RGC-32 in Epstein-Barr virus-immortalized cells.
Schlick SN; Wood CD; Gunnell A; Webb HM; Khasnis S; Schepers A; West MJ
PLoS One; 2011; 6(12):e28638. PubMed ID: 22163048
[TBL] [Abstract][Full Text] [Related]
3. Regulated Pumilio-2 binding controls RINGO/Spy mRNA translation and CPEB activation.
Padmanabhan K; Richter JD
Genes Dev; 2006 Jan; 20(2):199-209. PubMed ID: 16418484
[TBL] [Abstract][Full Text] [Related]
4. A combinatorial code for CPE-mediated translational control.
Piqué M; López JM; Foissac S; Guigó R; Méndez R
Cell; 2008 Feb; 132(3):434-48. PubMed ID: 18267074
[TBL] [Abstract][Full Text] [Related]
5. Involvement of Xenopus Pumilio in the translational regulation that is specific to cyclin B1 mRNA during oocyte maturation.
Nakahata S; Kotani T; Mita K; Kawasaki T; Katsu Y; Nagahama Y; Yamashita M
Mech Dev; 2003 Aug; 120(8):865-80. PubMed ID: 12963108
[TBL] [Abstract][Full Text] [Related]
6. The RNA binding domain of Pumilio antagonizes poly-adenosine binding protein and accelerates deadenylation.
Weidmann CA; Raynard NA; Blewett NH; Van Etten J; Goldstrohm AC
RNA; 2014 Aug; 20(8):1298-319. PubMed ID: 24942623
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program.
De Leo A; Arena G; Stecca C; Raciti M; Mattia E
Mol Cancer Res; 2011 Oct; 9(10):1346-55. PubMed ID: 21856773
[TBL] [Abstract][Full Text] [Related]
8. Cellular STAT3 functions via PCBP2 to restrain Epstein-Barr Virus lytic activation in B lymphocytes.
Koganti S; Clark C; Zhi J; Li X; Chen EI; Chakrabortty S; Hill ER; Bhaduri-McIntosh S
J Virol; 2015 May; 89(9):5002-11. PubMed ID: 25717101
[TBL] [Abstract][Full Text] [Related]
9. Response gene to complement 32 is required for C5b-9 induced cell cycle activation in endothelial cells.
Fosbrink M; Cudrici C; Tegla CA; Soloviova K; Ito T; Vlaicu S; Rus V; Niculescu F; Rus H
Exp Mol Pathol; 2009 Apr; 86(2):87-94. PubMed ID: 19162005
[TBL] [Abstract][Full Text] [Related]
10. Human Pumilio proteins recruit multiple deadenylases to efficiently repress messenger RNAs.
Van Etten J; Schagat TL; Hrit J; Weidmann CA; Brumbaugh J; Coon JJ; Goldstrohm AC
J Biol Chem; 2012 Oct; 287(43):36370-83. PubMed ID: 22955276
[TBL] [Abstract][Full Text] [Related]
11. Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes.
Klein G; Klein E; Kashuba E
Biochem Biophys Res Commun; 2010 May; 396(1):67-73. PubMed ID: 20494113
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr Virus (EBV)-BamHI-A Rightward Transcript (BART)-6 and Cellular MicroRNA-142 Synergistically Compromise Immune Defense of Host Cells in EBV-Positive Burkitt Lymphoma.
Zhou L; Bu Y; Liang Y; Zhang F; Zhang H; Li S
Med Sci Monit; 2016 Oct; 22():4114-4120. PubMed ID: 27796281
[TBL] [Abstract][Full Text] [Related]
13. IRF4 promotes Epstein-Barr virus activation in Burkitt's lymphoma cells.
Gao Y; Wang L; Lei Z; Li J; Forrest JC; Liang X
J Gen Virol; 2019 May; 100(5):851-862. PubMed ID: 30907723
[TBL] [Abstract][Full Text] [Related]
14. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
[TBL] [Abstract][Full Text] [Related]
15. Implications of polyadenylation in health and disease.
Curinha A; Oliveira Braz S; Pereira-Castro I; Cruz A; Moreira A
Nucleus; 2014; 5(6):508-19. PubMed ID: 25484187
[TBL] [Abstract][Full Text] [Related]
16. B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression.
Leucci E; Onnis A; Cocco M; De Falco G; Imperatore F; Giuseppina A; Costanzo V; Cerino G; Mannucci S; Cantisani R; Nyagol J; Mwanda W; Iriso R; Owang M; Schurfeld K; Bellan C; Lazzi S; Leoncini L
Int J Cancer; 2010 Mar; 126(6):1316-26. PubMed ID: 19530237
[TBL] [Abstract][Full Text] [Related]
17. Interferon-independent and -induced regulation of Epstein-Barr virus EBNA-1 gene transcription in Burkitt lymphoma.
Nonkwelo C; Ruf IK; Sample J
J Virol; 1997 Sep; 71(9):6887-97. PubMed ID: 9261415
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus provides a survival factor to Burkitt's lymphomas.
Kennedy G; Komano J; Sugden B
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14269-74. PubMed ID: 14603034
[TBL] [Abstract][Full Text] [Related]
19. Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency.
Pisano G; Roy A; Ahmed Ansari M; Kumar B; Chikoti L; Chandran B
Virol J; 2017 Nov; 14(1):221. PubMed ID: 29132393
[TBL] [Abstract][Full Text] [Related]
20. Latent membrane protein 1 of Epstein-Barr virus plays an important role in the serum starvation resistance of Epstein-Barr virus-immortalized B lymphocytes.
Park CH; Kim HR; Kim J; Jang SH; Lee KY; Chung GH; Jang YS
J Cell Biochem; 2004 Mar; 91(4):777-85. PubMed ID: 14991769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
